15456718

Source:http://linkedlifedata.com/resource/pubmed/id/15456718

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0024485, umls-concept:C0025664, umls-concept:C0031809, umls-concept:C0034866, umls-concept:C0039796, umls-concept:C0596087, umls-concept:C1548787
pubmed:dateCreated	2004-9-30
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0373125
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
pubmed:status	MEDLINE
pubmed:issn	0007-1285
pubmed:author	pubmed-author:BrindleK MKM, pubmed-author:EvelhochJ LJL, pubmed-author:GriffithsJ RJR, pubmed-author:HorsmanM RMR, pubmed-author:JacksonAA, pubmed-author:JaysonGG, pubmed-author:JudsonI RIR, pubmed-author:KnoppM VMV, pubmed-author:LeachM OMO, pubmed-author:MaxwellR JRJ, pubmed-author:McIntyreDD, pubmed-author:PadhaniA RAR, pubmed-author:PricePP, pubmed-author:RathboneRR, pubmed-author:RustinGG, pubmed-author:ToftsP SPS, pubmed-author:TozerG MGM, pubmed-author:VennartWW, pubmed-author:WatertonJ CJC, pubmed-author:WilliamsS RSR, pubmed-author:WorkmanPP
pubmed:issnType	Print
pubmed:volume	76 Spec No 1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S87-91
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15456718-Angiogenesis Inhibitors, pubmed-meshheading:15456718-Clinical Trials as Topic, pubmed-meshheading:15456718-Drug Design, pubmed-meshheading:15456718-Humans, pubmed-meshheading:15456718-Magnetic Resonance Angiography, pubmed-meshheading:15456718-Neoplasms, pubmed-meshheading:15456718-Neovascularization, Pathologic, pubmed-meshheading:15456718-Reproducibility of Results
pubmed:year	2003
pubmed:articleTitle	Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.
pubmed:affiliation	Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee (PTAC), Drug Development Office, Cancer Research UK, London, UK.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't